Brain scans could guide personalized OCD treatment
NCT ID NCT04786548
Summary
This study aims to see if brain inflammation levels can predict how well people with OCD respond to an anti-inflammatory medication. Researchers will use brain scans and blood tests to measure inflammation in 21 adults with OCD who are still experiencing symptoms despite current treatment. Participants will then take celecoxib for 8 weeks to see if those with higher inflammation show greater improvement in their OCD symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSESSIVE-COMPULSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
New York State Psychiatric Institute
New York, New York, 10032, United States
Conditions
Explore the condition pages connected to this study.